MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hortelano, S.
Right arrow Articles by Boscá, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hortelano, S.
Right arrow Articles by Boscá, L.



This article has been cited by other articles:


Home page
Hum ReprodHome page
S. Tartakover Matalon, A. Ornoy, A. Fishman, L. Drucker, and M. Lishner
The effect of 6-mercaptopurine on early human placental explants
Hum. Reprod., May 1, 2005; 20(5): 1390 - 1397.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Ordentlich, Y. Yan, S. Zhou, and R. A. Heyman
Identification of the Antineoplastic Agent 6-Mercaptopurine as an Activator of the Orphan Nuclear Hormone Receptor Nurr1
J. Biol. Chem., June 27, 2003; 278(27): 24791 - 24799.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. Y. Krynetski, N. F. Krynetskaia, M. E. Bianchi, and W. E. Evans
A Nuclear Protein Complex Containing High Mobility Group Proteins B1 and B2, Heat Shock Cognate Protein 70, ERp60, and Glyceraldehyde-3-Phosphate Dehydrogenase Is Involved in the Cytotoxic Response to DNA Modified by Incorporation of Anticancer Nucleoside Analogues
Cancer Res., January 1, 2003; 63(1): 100 - 106.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
P. R. Murphy, M. Limoges, F. Dodd, R. T. M. Boudreau, and C. K. L. Too
Fibroblast Growth Factor-2 Stimulates Endothelial Nitric Oxide Synthase Expression and Inhibits Apoptosis by a Nitric Oxide-Dependent Pathway in Nb2 Lymphoma Cells
Endocrinology, January 1, 2001; 142(1): 81 - 88.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S. HORTELANO, M. CASTILLA, A. M. TORRES, A. TEJEDOR, and L. BOSCÁ
Potentiation by Nitric Oxide of Cyclosporin A and FK506-Induced Apoptosis in Renal Proximal Tubule Cells
J. Am. Soc. Nephrol., December 1, 2000; 11(12): 2315 - 2323.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
A. Allione, P. Bernabei, M. Bosticardo, S. Ariotti, G. Forni, and F. Novelli
Nitric Oxide Suppresses Human T Lymphocyte Proliferation Through IFN-{gamma}-Dependent and IFN-{gamma}-Independent Induction of Apoptosis
J. Immunol., October 15, 1999; 163(8): 4182 - 4191.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. W. Parker, G. Kaur, W. Nieves-Neira, M. Taimi, G. Kohlhagen, T. Shimizu, M. D. Losiewicz, Y. Pommier, E. A. Sausville, and A. M. Senderowicz
Early Induction of Apoptosis in Hematopoietic Cell Lines After Exposure to Flavopiridol
Blood, January 15, 1998; 91(2): 458 - 465.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1997 by the American Society for Pharmacology and Experimental Therapeutics